510 related articles for article (PubMed ID: 10550166)
1. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ
J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166
[TBL] [Abstract][Full Text] [Related]
2. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
Bennett CL; Smith TJ; Weeks JC; Bredt AB; Feinglass J; Fetting JH; Hillner BE; Somerfield MR; Winn RJ
J Clin Oncol; 1996 Sep; 14(9):2511-20. PubMed ID: 8823330
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
J Clin Oncol; 1994 Nov; 12(11):2471-508. PubMed ID: 7964965
[TBL] [Abstract][Full Text] [Related]
4. The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
Bennett CL; Bishop MR; Tallman MS; Somerfield MR; Feinglass J; Smith TJ
Ann Oncol; 1999 Nov; 10(11):1355-9. PubMed ID: 10631465
[TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
6. Growth factor usage patterns and outcomes in the community setting: collection through a practice-based computerized clinical information system.
Swanson G; Bergstrom K; Stump E; Miyahara T; Herfindal ET
J Clin Oncol; 2000 Apr; 18(8):1764-70. PubMed ID: 10764438
[TBL] [Abstract][Full Text] [Related]
7. Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
Parsons SK; Mayer DK; Alexander SW; Xu R; Land V; Laver J
J Pediatr Hematol Oncol; 2000; 22(3):227-41. PubMed ID: 10864054
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations.
Bennett CL; Somerfield MR; Pfister DG; Tomori C; Yakren S; Bach PB;
J Clin Oncol; 2003 Mar; 21(5):937-41. PubMed ID: 12610197
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor use in cancer patients.
Baker J; McCune JS; Harvey RD; Bonsignore C; Lindley CM
Ann Pharmacother; 2000; 34(7-8):851-7. PubMed ID: 10928394
[TBL] [Abstract][Full Text] [Related]
10. Use of granulocyte colony-stimulating factor (G-CSF) in clinical practice in Fukuoka City area in Japan.
Tamura K
Fukuoka Igaku Zasshi; 1999 Jun; 90(6):279-85. PubMed ID: 10423924
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges.
Somerfield MR; Einhaus K; Hagerty KL; Brouwers MC; Seidenfeld J; Lyman GH;
J Clin Oncol; 2008 Aug; 26(24):4022-6. PubMed ID: 18711193
[TBL] [Abstract][Full Text] [Related]
12. The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.
Debrix I; Tilleul P; Milleron B; Grené N; Bouleuc C; Roux D; Lioté H; Madelaine I; Bellanger A; Conort O; Fontan JE; Le Mercier F; Bardin C; Becker A
Clin Ther; 2001 Jul; 23(7):1116-27. PubMed ID: 11519774
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
14. G-CSF as prophylaxis of febrile neutropenia in SCLC.
Adams JR; Lyman GH; Djubegovic B; Feinglass J; Bennett CL
Expert Opin Pharmacother; 2002 Sep; 3(9):1273-81. PubMed ID: 12186620
[TBL] [Abstract][Full Text] [Related]
15. Use of granulocyte colony-stimulating factor: a survey among Italian medical oncologists.
Danova M; Rosti G; De Placido S; Bencardino K; Venturini M
Oncol Rep; 2005 Dec; 14(6):1405-12. PubMed ID: 16273232
[TBL] [Abstract][Full Text] [Related]
16. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
17. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
Smith TJ; Khatcheressian J; Lyman GH; Ozer H; Armitage JO; Balducci L; Bennett CL; Cantor SB; Crawford J; Cross SJ; Demetri G; Desch CE; Pizzo PA; Schiffer CA; Schwartzberg L; Somerfield MR; Somlo G; Wade JC; Wade JL; Winn RJ; Wozniak AJ; Wolff AC
J Clin Oncol; 2006 Jul; 24(19):3187-205. PubMed ID: 16682719
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
Smith TJ; Bohlke K; Lyman GH; Carson KR; Crawford J; Cross SJ; Goldberg JM; Khatcheressian JL; Leighl NB; Perkins CL; Somlo G; Wade JL; Wozniak AJ; Armitage JO;
J Clin Oncol; 2015 Oct; 33(28):3199-212. PubMed ID: 26169616
[TBL] [Abstract][Full Text] [Related]
19. [Appropriate use of granulocyte colony-stimulating factor in the management of hematologic malignancies].
Usui N
Gan To Kagaku Ryoho; 2014 Jun; 41(6):694-701. PubMed ID: 25129082
[TBL] [Abstract][Full Text] [Related]
20. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]